Please login to the form below

Not currently logged in
Email:
Password:

Havas Life London Award for Customer Focus Excellence via Digital/Social Media

Sponsored by

Finalist

Digital Strategy for the Boehringer Ingelheim Oncology Franchise

Boehringer Ingelheim in association with infill Kommunikation GmbH


Summary of work

Boehringer Ingelheim’s (BI) global digital strategy for the oncology franchise is an interconnected and multichannel approach offering quality medical information and education to different target groups, while working under tight legal restrictions for communicating not-yet licensed drugs. Target groups of interest are opinion leaders, healthcare professionals, the media and patients. 

The main components of the strategy are:

  • Intense communication of the global strategy to the regional affiliates
  • GLOW Portal which connects opinion leaders
  • An eNewsletter that connects initiatives quickly with target groups
  • Attractive apps and tools that provide value 
  • Constant SEO, SEM and content updates drive traffic and promote initiatives.
The information communicated to the target groups resulted from feedback from international oncology societies, patient advocacy groups and extensive market research.

All the websites were developed with a CMS (content management system) backend to enable consistency in design, structure and contents used for spinoffs by regional BI affiliates. 

BI’s digital strategy is synergistic and successful in reaching the target audiences, while positioning BI as a trusted name in the world of oncology.

 

 

Executive summary as submitted


COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...